Deutsche Bank AG grew its holdings in shares of Davita Inc (NYSE:DVA) by 116.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 406,542 shares of the company’s stock after buying an additional 219,055 shares during the period. Deutsche Bank AG owned 0.22% of Davita worth $29,369,000 as of its most recent SEC filing.
Several other hedge funds have also made changes to their positions in the company. Coastline Trust Co raised its position in shares of Davita by 6.3% in the 4th quarter. Coastline Trust Co now owns 16,120 shares of the company’s stock worth $1,165,000 after purchasing an additional 950 shares during the last quarter. Public Employees Retirement Association of Colorado raised its position in shares of Davita by 3.5% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 29,076 shares of the company’s stock worth $2,101,000 after purchasing an additional 974 shares during the last quarter. Creative Planning raised its position in shares of Davita by 8.6% in the 4th quarter. Creative Planning now owns 13,137 shares of the company’s stock worth $949,000 after purchasing an additional 1,044 shares during the last quarter. Crossmark Global Holdings Inc. raised its position in shares of Davita by 7.0% in the 4th quarter. Crossmark Global Holdings Inc. now owns 25,163 shares of the company’s stock worth $1,818,000 after purchasing an additional 1,650 shares during the last quarter. Finally, Amalgamated Bank raised its position in shares of Davita by 9.7% in the 4th quarter. Amalgamated Bank now owns 19,246 shares of the company’s stock worth $1,391,000 after purchasing an additional 1,698 shares during the last quarter. Hedge funds and other institutional investors own 85.79% of the company’s stock.
In other Davita news, insider James K. Hilger sold 3,572 shares of the business’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $78.95, for a total value of $282,009.40. Following the completion of the transaction, the insider now owns 33,649 shares of the company’s stock, valued at approximately $2,656,588.55. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.00% of the stock is currently owned by insiders.
Several equities analysts have recently issued reports on DVA shares. Raymond James Financial raised Davita from an “outperform” rating to a “strong-buy” rating and lifted their price target for the stock from $65.00 to $84.00 in a research report on Thursday, December 7th. Bank of America raised Davita from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $75.00 to $85.00 in a research report on Thursday, January 4th. Citigroup raised Davita from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $67.71 to $82.00 in a research report on Monday, December 11th. SunTrust Banks set a $75.00 price target on Davita and gave the stock a “hold” rating in a research report on Thursday, December 21st. Finally, Zacks Investment Research raised Davita from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 2nd. Two analysts have rated the stock with a sell rating, five have given a hold rating, four have assigned a buy rating and two have given a strong buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $79.30.
Davita Inc (NYSE DVA) opened at $68.41 on Tuesday. Davita Inc has a 52-week low of $52.51 and a 52-week high of $80.71. The company has a debt-to-equity ratio of 1.87, a current ratio of 2.88 and a quick ratio of 2.82. The firm has a market capitalization of $12,472.46, a PE ratio of 19.92, a price-to-earnings-growth ratio of 0.99 and a beta of 1.03.
Davita (NYSE:DVA) last issued its earnings results on Tuesday, February 13th. The company reported $0.92 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.94 by ($0.02). Davita had a return on equity of 12.86% and a net margin of 4.65%. The business had revenue of $2.78 billion during the quarter, compared to analysts’ expectations of $3.90 billion. During the same period last year, the firm posted $0.98 EPS. equities analysts forecast that Davita Inc will post 4.15 earnings per share for the current year.
ILLEGAL ACTIVITY WARNING: This report was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/03/20/deutsche-bank-ag-increases-stake-in-davita-inc-dva.html.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.